KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Leases: 2017-2025

Historic Leases for BeOne Medicines (ONC) over the last 7 years, with Sep 2025 value amounting to $140.2 million.

  • BeOne Medicines' Leases rose 38.77% to $140.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.2 million, marking a year-over-year increase of 38.77%. This contributed to the annual value of $139.3 million for FY2024, which is 46.32% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Leases is $140.2 million, which was down 3.81% from $145.8 million recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Leases peaked at $146.4 million during Q1 2025, and registered a low of $86.9 million during Q1 2021.
  • In the last 3 years, BeOne Medicines' Leases had a median value of $103.6 million in 2024 and averaged $115.1 million.
  • Its Leases has fluctuated over the past 5 years, first declined by 19.49% in 2024, then spiked by 66.86% in 2025.
  • Quarterly analysis of 5 years shows BeOne Medicines' Leases stood at $117.4 million in 2021, then declined by 6.36% to $110.0 million in 2022, then decreased by 13.42% to $95.2 million in 2023, then skyrocketed by 46.32% to $139.3 million in 2024, then skyrocketed by 38.77% to $140.2 million in 2025.
  • Its last three reported values are $140.2 million in Q3 2025, $145.8 million for Q2 2025, and $146.4 million during Q1 2025.